Life Sciences and Healthcare

Overcoming health inequity in the U.S. and the role of telehealth [PODCAST]

In this episode of Conversations in Healthcare,  leaders from Cigna, Henry Ford Health System and eHI discuss how telehealth can help bridge care gaps. Download our new report at right for latest analysis of telehealth’s potential to address healthcare inequities.     Since the start of 2020, the healthcare sector has shown remarkable resilience in […]

Innovative cardiovascular treatments: Top pharmacotherapy breakthroughs at AHA21

Clarivate experts share takeaways from the 2021 American Heart Association Scientific Sessions (AHA21), with insights on how findings may impact patient care. As part of our Drugs to Watch™ series, which reviews therapies expected to have significant impact on healthcare markets, Clarivate experts have selected their top picks from the AHA21 Scientific Sessions. This completely […]

How the pandemic shifted Roche’s priorities and R&D investments [PODCAST]

In this episode of Conversations in Healthcare, Richard Erwin discusses how Roche Products Limited (UK) has evolved their strategy during the pandemic.     In the past two years months, the healthcare industry demonstrated how it can mobilize its resources to tackle what has been one of the greatest healthcare challenges in history. During One […]

Optimizing patient-first clinical trials with advanced site intelligence [PODCAST]

Learnings from bringing clinical trial management in-house, and how to modernize your approach to patient-first trials with advanced data science, real-world data and other patient intelligence   One of the biggest challenges for the pharmaceutical industry is the efficiency of the product cycle for creating new medicines. A great determining step in that process is […]

Showing the value of regulatory intelligence in pharma [Podcast]

In this episode of Conversations in Healthcare, Carolyn Hynes from AstraZeneca discusses the importance of regulatory intelligence. In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership, Life Science & Healthcare at Clarivate, speaks with Carolyn Hynes, Director of Regulatory Intelligence at AstraZeneca and Celine Rodier, Senior Health Policy Manager at […]

Guided by science to accelerate innovation

Women leaders at Clarivate like Ann Graul play a key role in accelerating innovation in the quest for answers to COVID-19 issues. Watch their story. The global COVID-19 pandemic that began in early 2020 turned the world as we knew it upside down, bringing unimagined challenges and exacerbating existing struggles. It impacted how people work […]

Bioinfogate becomes Clarivate

This year, Clarivate acquired Bioinfogate, a leading provider of analytics solutions in the life sciences and producer of the OFF-X™ portal. The move further expands and integrates drug toxicity data and translational safety intelligence from OFF-X into all aspects of the life science cycle. In combination with the Clarivate portfolio of solutions, Bioinfogate provides critical translational […]

COVID-19: Fighting a global pandemic with innovation

In this episode of Ideas to Innovation, Clarivate life sciences and healthcare experts reflect on partnering with pharma to combat the pandemic. Listen now.   COVID-19 has presented an enormous global challenge, requiring an unprecedented level of engagement by stakeholders across pharma, research and policy. While SARS-CoV-2 emerged as a novel virus to which humans […]